Tumor Necrosis Factor Plays an Essential Role in Determining Hypersensitivity Pneumonitis in a Mouse Model
- 1 November 1991
- journal article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 5 (5) , 477-483
- https://doi.org/10.1165/ajrcmb/5.5.477
Abstract
We examined the importance of the cytokine tumor necrosis factor-alpha (TNF-alpha) in a mouse model of hypersensitivity pneumonitis (HP). Mice of the C57BL/6 strain were instilled intranasally 3 days/wk for 3 wk with 150 micrograms of the actinomycete Faenia rectivirgula (Micropolyspora faeni) to induce HP as a model of farmer's lung. This experimental model was associated with a progressive inflammation in the lungs of challenged mice, seen histologically as cellular infiltrates of large quantities of macrophages and lymphocytes and some neutrophils. The disease in challenged mice treated with a control rabbit serum was also associated with a substantial release of tumor TNF-alpha (up to 80 U/ml of TNF-alpha in the bronchoalveolar lavage [BAL] at 3 wk after beginning of treatment) and interleukin-1, which peaked at 1 wk (approximately 300 U/ml) and diminished thereafter. A very large increase in BAL cell number (11-fold increase versus saline controls) and an enhanced release potential for TNF-alpha by alveolar macrophages was also seen. Lung fibrosis was also evident in challenged animals, as demonstrated by a 2-fold increase in hydroxyproline levels. Infusion of challenged mice with a rabbit polyclonal antibody against TNF-alpha (2 mg/wk) completely abrogated the disease, as mice so treated had normal lung histology. Anti-TNF-alpha blocked cellular recruitment in the lungs (only a 2-fold increase at week 3); it also completely abolished TNF-alpha secretion in the BAL and drastically reduced interleukin-1 levels in this fluid. Anti-TNF-alpha also abolished lung index increases and lung fibrosis, with both parameters similar to that of saline-instilled mice.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 20 references indexed in Scilit:
- Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteriaClinical and Experimental Immunology, 1991
- Recent advances in pathogenesis of allergic alveolitisClinical and Experimental Allergy, 1990
- Cyclosporine a inhibits TNF production without decreasing TNF mRNA levelsBiochemical and Biophysical Research Communications, 1989
- Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.The Journal of cell biology, 1988
- Experimental hypersensitivity pneumonitis in the mouse: Histologic and immunologic features and their modulation with cyclosporin AJournal of Allergy and Clinical Immunology, 1988
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophagesBiochemical and Biophysical Research Communications, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Hypersensitivity PneumonitisSeminars in Respiratory and Critical Care Medicine, 1984